EQS-NVR: Marinomed Biotech AG: Release according to Article 135, Section 1 BörseG with the objective of Europe-wide distribution
Werte in diesem Artikel
|
EQS Total Voting Rights Announcement: Marinomed Biotech AG
/ Total Voting Rights Announcement
Werbung Werbung Marinomed Biotech AG hereby announces, in accordance with Section 135 (1) of the Austrian Stock Exchange Act (BörseG), that as a result of the resolution on the capital increase dated September 16, 2025, the total number of voting rights at the end of October 2025 has increased to 1,839,940, and the new share capital of the company amounts to EUR 1,839,940. The change in the total number of voting rights took effect upon entry of the capital increase in the commercial register on October 3, 2025.
31.10.2025 CET/CEST |
| Language: | English |
| Company: | Marinomed Biotech AG |
| Hovengasse 25 | |
| 2100 Korneuburg | |
| Austria | |
| Internet: | www.marinomed.com |
| End of News | EQS News Service |
|
|
2219724 31.10.2025 CET/CEST
Ausgewählte Hebelprodukte auf Marinomed Biotech
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Marinomed Biotech
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|